OCUP (ocuphire.com) יחס שווי שוק לשווי בספרים
Ocuphire Pharma, Inc. (OCUP) demonstrates resilience to economic downturns, as demand for ophthalmology remains independent of GDP dynamics. Effective distribution through regional hubs minimizes drug shortages, thereby supporting margins. The current market capitalization-to-book value ratio stands at 0.74, while the commercialization of pupil drops and anticipated Phase 3 data create powerful growth drivers.
%3A%20%D7%A9%D7%95%D7%95%D7%99%20%D7%A9%D7%95%D7%A7%20%D7%91%D7%99%D7%97%D7%A1%20%D7%9C%D7%A0%D7%9B%D7%A1%D7%99%D7%9D%20%D7%A0%D7%A7%D7%99%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_OCUP_-_Ocuphire-Pharma-Inc._-_Market-Capitalization-to-Net-Assets "OCUP יחס שווי שוק לערך בספרים Ocuphire Corporation (04.07.2022 - 24.10.2024) | 👁️GURU.Markets👁️")
פילוחי מדדים פיננסיים ומדדי שוק עבור Ocuphire Pharma Inc (OCUP)
This metric calculates the gap between a business's market value and its net assets, measuring the market premium or discount to book value to identify overvaluation or a hidden crisis. For Ocuphire Pharma, Inc. (OCUP), steady demand for Nyxol and growth in free cash flow should support high asset values. By analyzing the ratio of the company's market capitalization to its book value, an investor assesses the relevance of its fundamental value.